Published in Ann Rheum Dis on May 01, 2001
Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis (2004) 1.54
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol (2010) 1.43
Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis (2004) 1.35
Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome. Ann Rheum Dis (2005) 1.24
Advances in understanding the pathogenesis of primary Sjögren's syndrome. Nat Rev Rheumatol (2013) 1.16
Identification of specific autoantigens in Sjögren's syndrome by SEREX. Immunology (2005) 1.05
Progression of salivary gland dysfunction in patients with Sjogren's syndrome. Ann Rheum Dis (2006) 1.00
Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis. Rheumatol Int (2014) 0.95
Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas. Haematologica (2009) 0.95
Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update. J Cancer Epidemiol (2012) 0.95
Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome. Clin Exp Immunol (2005) 0.92
Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) (2015) 0.87
Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome. Ann Rheum Dis (2005) 0.86
[Epidemiology of primary Sjörgren's syndrome]. Z Rheumatol (2010) 0.84
[Sjögren's syndrome. Current aspects from a rheumatological point of view]. Z Rheumatol (2006) 0.82
Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study. Arthritis Res Ther (2015) 0.82
Clinical Characteristics and Outcome of Primary Sjogren's Syndrome: A Large Asian Indian Cohort. Open Rheumatol J (2015) 0.79
Clinical course, prognosis, and cause of death in primary Sjögren's syndrome. J Immunol Res (2014) 0.79
Current Aspects of Pathogenesis in Sjögren's Syndrome. Ther Adv Musculoskelet Dis (2010) 0.78
STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome. Clin Exp Immunol (2015) 0.78
Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up. Clin Rheumatol (2016) 0.78
ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome? RMD Open (2015) 0.76
The Association Between Sjögren Syndrome and Adverse Postoperative Outcomes: A Historical Cohort Study Using Administrative Health Data. Anesth Analg (2015) 0.75
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement. Clin Rheumatol (2017) 0.75
SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) (1965) 7.46
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum (1993) 7.14
Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol (1968) 6.61
Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum (1986) 6.11
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med (1964) 4.07
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum (1999) 2.99
Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med (1967) 2.92
The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients. Rheumatology (Oxford) (1999) 1.82
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum (1996) 1.76
Primary Sjögren's syndrome in north east England--a longitudinal study. Br J Rheumatol (1991) 1.64
Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome. Br J Rheumatol (1993) 1.53
Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol (1995) 1.50
Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum (1996) 1.23
Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum (1998) 1.22
Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. N Engl J Med (1975) 1.19
Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control (1997) 1.18
Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: a clinicopathologic study of 13 patients. Hum Pathol (1991) 1.17
Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol (1992) 1.11
Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. Rheumatology (Oxford) (1999) 1.08
Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial. Ann Rheum Dis (1993) 1.01
The clinical picture of primary Sjögren's syndrome: a retrospective study. J Rheumatol (1983) 1.01
Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992. J Rheumatol (1999) 0.94
Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome: a clinical and immunopathologic study. Hum Pathol (1990) 0.91
Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both). Ann Rheum Dis (1999) 0.90
T cell lymphoma occurring in Sjögren's syndrome. Arthritis Rheum (1984) 0.89
Lymphoma in Sjogren's syndrome. Med Pediatr Oncol (1992) 0.89
Lymphoma in Sjögren's syndrome. From histopathology to molecular pathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 0.88
Primary Sjögren's syndrome: clinical spectrum and mode of presentation based on an analysis of 50 patients selected from a department of rheumatology. Neth J Med (1992) 0.87
T cell lymphoma in a patient with longstanding rheumatoid arthritis and Sjögren's syndrome. Arthritis Rheum (1987) 0.86
Antibody and immunoglobulin levels in aged humans. Arch Gerontol Geriatr (1984) 0.84
Sjögren's syndrome terminating with multiple myeloma. Scand J Rheumatol (1995) 0.83
Relationship between immunoglobulin levels and specific antibody titers in the elderly. Z Gerontol (1986) 0.83
Restriction of immunoglobulin heterogeneity, autoimmunity and serum protein levels in aged people. Clin Exp Immunol (1976) 0.80
Sjögren's syndrome with specific cutaneous manifestations and multifocal clonal T-cell populations progressing to a cutaneous pleomorphic T-cell lymphoma. Am J Clin Pathol (1989) 0.80
Development of Hodgkin's disease in the course of primary Sjögren's syndrome. Br J Rheumatol (1992) 0.78
Hodgkin's disease occurring in primary Sjögren's syndrome. Ann Rheum Dis (1990) 0.78
Sjögren's syndrome and pleomorphic T-cell lymphoma presenting with skin involvement. J R Soc Med (1988) 0.77
Chronic myelomonocytic leukemia and primary Sjögren's syndrome. Clin Rheumatol (1988) 0.77
Low-grade lymphoma of immature T-cell phenotype in a case of lymphocytic interstitial pneumonia and Sjögren's syndrome. Histopathology (1987) 0.77
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (2001) 6.23
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol (1994) 4.89
Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A (2001) 3.31
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest (1982) 3.29
Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol (1995) 3.28
Coeliac disease--associated disorders and survival. Gut (1994) 3.13
Aggressiveness of screen-detected breast cancers. Lancet (1995) 3.07
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx assays for detection of Chlamydia trachomatis infection in women by using urine specimens. J Clin Microbiol (1997) 2.73
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ (1997) 2.41
Social class as a prognostic factor in breast cancer survival. Cancer (1990) 2.37
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Risk of cancer in Finnish children living close to power lines. BMJ (1993) 2.29
Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology (2000) 2.25
Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry (2001) 2.23
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant (2000) 2.18
Longitudinal study of maternal depressive symptoms and child well-being. J Am Acad Child Adolesc Psychiatry (2001) 2.18
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
From cross-tabulations to multipurpose exposure information systems: a new job-exposure matrix. Am J Ind Med (1998) 2.07
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07
Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06
Progression of asbestosis predicts lung cancer. Chest (1998) 2.02
Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med (1995) 1.97
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93
Detection of Chlamydia trachomatis infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimens. J Clin Microbiol (1996) 1.89
Multiple cancer--an epidemiologic exercise in Finland. J Natl Cancer Inst (1985) 1.87
Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect (1999) 1.84
Work-related cancer in the Nordic countries. Scand J Work Environ Health (1999) 1.84
Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol (1999) 1.84
Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol (1995) 1.84
Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol (1999) 1.83
The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients. Rheumatology (Oxford) (1999) 1.82
Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest (1983) 1.82
Chlamydial endometritis. J Clin Pathol (1985) 1.80
Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol (1997) 1.74
Biogenesis of podocalyxin--the major glomerular sialoglycoprotein--in the newborn rat kidney. Eur J Cell Biol (1989) 1.74
Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol (2000) 1.71
Effect of work with visual display units on musculo-skeletal disorders in the office environment. Occup Med (Lond) (2003) 1.71
Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect (2007) 1.69
Detection of Mycobacterium tuberculosis complex in sputum specimens by the automated Roche Cobas Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol (1998) 1.68
Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1987) 1.65
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64
Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med (1999) 1.63
Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1989) 1.62
Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet (2005) 1.61
Incidence of disorders of spermatogenesis in middle aged finnish men, 1981-91: two necropsy series. BMJ (1997) 1.60
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60
Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum (2001) 1.59
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer (2000) 1.59
Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis (1994) 1.59
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol (1993) 1.58
Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol (1996) 1.58
Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med (1995) 1.56
Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. J Exp Med (1992) 1.56
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer (1999) 1.56
Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol (1997) 1.56
Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest (1984) 1.56
Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: nationwide cohort study. BMJ (1996) 1.55
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Autoimmune thyroid disorders and coeliac disease. Eur J Endocrinol (1994) 1.55
Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol (1996) 1.55
Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Selective IgA deficiency and coeliac disease. Scand J Gastroenterol (1992) 1.53
Moderate alcohol consumption and loss of cerebellar Purkinje cells. BMJ (1994) 1.53
Death rates and causes of death in patients with rheumatoid arthritis: a population-based study. Scand J Rheumatol (2004) 1.53
Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer (1995) 1.52
Physiological factors and medications as predictors of injurious falls by elderly people: a prospective population-based study. Age Ageing (1996) 1.52
Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract (2004) 1.52
CSF and MRI findings in patients with acute herpes zoster. Neurology (1998) 1.49
Selective screening: theory and practice based on high-risk groups of cervical cancer. J Epidemiol Community Health (1979) 1.48
Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol (2001) 1.46
Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease. Lancet (1992) 1.45
Diurnal variations of serum and urine creatine and creatinine. Scand J Clin Lab Invest (1971) 1.45
Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest (1981) 1.45
Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen (1999) 1.45
Disability pensions in severely disturbed in-patient adolescents. Twenty-year prospective study. Br J Psychiatry (1998) 1.44
Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am J Clin Pathol (1983) 1.44
Anatomic sites of upper genital tract infection. Obstet Gynecol (1985) 1.41
Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am J Pathol (1999) 1.40
Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol (2012) 1.40
Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int (1996) 1.40
Stability over time of serum antibody levels to human papillomavirus type 16. J Infect Dis (1998) 1.39
Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol (2001) 1.39
Mycoplasmas and leukaemia. Res Virol (1992) 1.39
Heymann nephritis induced by kidney brush border glycoproteins. Lab Invest (1980) 1.39